DuChemBIO Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	6,480	7,994	4,001
Depreciation & Amortization	6,870	5,565	5,760
Loss (Gain) From Sale of Assets	-2.85	0.18	-16.28
Asset Writedown & Restructuring Costs	72.81	-	30.7
Loss (Gain) From Sale of Investments	-207.24	-387.82	-92.13
Loss (Gain) on Equity Investments	24.69	-1,106	69.64
Stock-Based Compensation	58.65	31.97	236.54
Provision & Write-off of Bad Debts	-119.23	156.15	-165.84
Other Operating Activities	589.68	-2,039	929.66
Change in Accounts Receivable	-1,865	-1,834	-131.89
Change in Inventory	263.61	-74.64	-534.11
Change in Accounts Payable	-137.55	-597.38	411.37
Change in Other Net Operating Assets	-2,088	-679.24	-2,057
Operating Cash Flow	9,939	7,029	8,441
Operating Cash Flow Growth	41.40%	-16.73%	-
Capital Expenditures	-865.67	-1,589	-1,147
Sale of Property, Plant & Equipment	-	-	31
Sale (Purchase) of Intangibles	-12.16	-283.1	-150
Investment in Securities	-	11.06	-
Other Investing Activities	120	-204.41	-132.8
Investing Cash Flow	-757.82	-1,816	-1,299
Long-Term Debt Issued	1,000	-	-
Long-Term Debt Repaid	-5,422	-7,925	-7,766
Net Debt Issued (Repaid)	-4,422	-7,925	-7,766
Issuance of Common Stock	-	11,440	-
Other Financing Activities	-	-7.75	-
Financing Cash Flow	-4,422	3,507	-7,766
Foreign Exchange Rate Adjustments	-0.06	-	-0.19
Net Cash Flow	4,760	8,720	-624.54
Free Cash Flow	9,074	5,440	7,293
Free Cash Flow Growth	66.81%	-25.41%	-
Free Cash Flow Margin	23.52%	15.28%	21.02%
Free Cash Flow Per Share	319.36	202.48	272.63
Cash Interest Paid	800.08	1,087	919.41
Cash Income Tax Paid	259.56	144.92	90.38
Levered Free Cash Flow	8,061	4,629	-
Unlevered Free Cash Flow	8,724	5,311	-
Change in Working Capital	-3,827	-3,185	-2,312

Source: S&P Capital IQ. Standard template. Financial Sources.